Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.

Saved in:
Bibliographic Details
Title: Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
Authors: Gedde-Dahl A; Faculty of Health Sciences, Oslo Metropolitan University, P.O. Box 4 St. Olavs plass, N-0130, Oslo, Norway. ane.gedde-dahl@oslomet.no., Spigset O; Department of Clinical Pharmacology, St. Olav's University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Molden E; Department of Pharmacy, University of Oslo, Oslo, Norway.; Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2022 Oct; Vol. 78 (10), pp. 1623-1632. Date of Electronic Publication: 2022 Jul 25.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1041
DOI:10.1007/s00228-022-03364-5